'Hearts and minds': association, causation and implication of cognitive impairment in heart failure
artículo científico publicado en 2015
17ss oestradiol does not attenuate the response to angiotensin I and II during long term therapy in postmenopausal women
artículo científico publicado en 2004
2010 Focused Update of ESC Guidelines on device therapy in heart failure
article published November 2010 in European Journal of Heart Failure
2010 Focused Update of ESC Guidelines on device therapy in heart failure
article published 1 November 2010 in EP Europace
2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
artículo científico publicado en 2013
2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary
article
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
artículo científico publicado en 2013
2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines
artículo científico publicado en 2013
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
article by Paulus Kirchhof et al published 27 August 2016 in EP Europace
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
artículo científico publicado en 2016
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.
artículo científico publicado en 2018
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.
artículo científico publicado en 2018
A comparison of laryngeal mask airway with tracheal tube for intra-ocular ophthalmic surgery
artículo científico publicado el 1 de agosto de 1992
A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland
artículo científico publicado en 2007
A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk.
artículo científico publicado en 2013
A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study.
artículo científico publicado en 2002
A prediction model for sudden cardiac death in patients with heart failure and preserved ejection fraction
artículo científico publicado en 2014
A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure
artículo científico publicado en 2015
A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction
scientific article published on 28 March 2020
A qualitative study of the contribution of pharmacists to heart failure management in Scotland
artículo científico publicado en 2005
A randomised trial of a pre-synaptic stimulator of DA2-dopaminergic and alpha2-adrenergic receptors on morbidity and mortality in patients with heart failure
artículo científico publicado en 2007
A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure
artículo científico publicado en 2007
A review of quality-of-life evaluations in patients with congestive heart failure.
artículo científico publicado en 1999
A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics
artículo científico publicado en 2005
A systematic review of event rates in clinical trials in diabetes mellitus: the importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial design
scientific article published on January 2011
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
artículo científico publicado en 2009
A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)
scientific article published on 21 March 2019
A1 H spin echo and 51V NMR study of the interaction of vanadate with intact erythrocytes
ACE Inhibitors after myocardial Infarctlon
artículo científico publicado en 1993
ACE inhibitors and health-care economics
⬇️
artículo científico publicado el 1 de abril de 1995
ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
artículo científico publicado en 2001
Acute Heart Failure and Atrial Fibrillation: Insights From the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF) Trial
artículo científico publicado en 2015
Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF Study
artículo científico publicado en 2016
Acute decompensated heart failure patients admitted to critical care units: insights from ASCEND-HF.
artículo científico publicado en 2014
Acute effects of captopril on the renal actions of furosemide in patients with chronic heart failure
artículo científico publicado en 1993
Acute heart failure in the elderly: differences in clinical characteristics, outcomes, and prognostic factors in the VERITAS Study
artículo científico publicado en 2015
Acute heart failure: have we got it all wrong?
article
Acute ischemic events in HF—should we include sudden death?
artículo científico publicado en 2011
Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial
artículo científico publicado en 2005
Adherence to medication according to sex and age in the CHARM programme
article
Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology
artículo científico publicado en 2007
Age- and Sex-Specific Trends in Fatal Incidence and Hospitalized Incidence of Stroke in Scotland, 1986 to 2005
article
Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction
artículo científico publicado en 2019
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
scientific article published in The Lancet
Albuminuria in chronic heart failure: prevalence and prognostic importance
artículo científico publicado en 2009
Aldosterone Does Not Predict Cardiovascular Events Following Acute Coronary Syndrome in Patients Initially Without Heart Failure.
artículo científico
Aldosterone and cortisol predict medium-term left ventricular remodelling following myocardial infarction.
artículo científico publicado en 2011
Aldosterone status associated with insulin resistance in patients with heart failure--data from the ALOFT study.
artículo científico publicado en 2009
Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design
artículo científico publicado en 2009
Aliskiren alone or in combination with enalapril vs. enalapril among patients with chronic heart failure with and without diabetes: a subgroup analysis from the ATMOSPHERE trial
artículo científico publicado en 2017
Aliskiren in type 2 diabetes and cardiorenal end points
artículo científico publicado en 2013
Aliskiren, ALTITUDE, and the implications for ATMOSPHERE.
artículo científico
Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure
artículo científico publicado en 2016
Aliskiren, Enalapril, or Both in Heart Failure
artículo científico publicado en 2016
Alteration of the erythrocyte glutathione redox balance by N -acetylcysteine, captopril and exogenous glutathione
article
Altered diaphragm position and function in patients with chronic heart failure
article
Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality
artículo científico publicado en 2007
Amlodipine for all undergoing PCI? The evidence is unconvincing
article
An economic analysis of specialist heart failure nurse management in the UK; can we afford not to implement it?
artículo científico publicado en 2002
An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial
artículo científico publicado en 2010
An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry
artículo científico publicado en 2004
Anaemia is an independent predictor of mortality in patients with left ventricular systolic dysfunction following acute myocardial infarction☆
Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved
⬇️
artículo científico publicado en 2013
Analysis of reproducibility of reference lumen quantitation with intravascular ultrasound in stented coronary arteries.
artículo científico publicado en 1997
Anemia and heart failure
artículo científico publicado en 2004
Anemia and its relationship to clinical outcome in heart failure.
artículo científico publicado en 2004
Angina and intermittent claudication in 7403 participants of the 2003 Scottish Health Survey: impact on general and mental health, quality of life and five-year mortality.
artículo científico publicado en 2012
Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial
artículo científico publicado en 2017
Angiotensin Receptor-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction: Lessons from PARAGON-HF
scientific article published on 02 August 2020
Angiotensin receptor blockers and heart failure: still CHARMing after VALIANT?
artículo científico publicado en 2004
Angiotensin receptor blockers in heart failure
⬇️
artículo científico publicado el 1 de septiembre de 2003
Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure
artículo científico publicado en 2014
Angiotensin receptor-neprilysin inhibitors: A new paradigm in heart failure with reduced ejection fraction
artículo científico publicado en 2018
Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure with Preserved Ejection Fraction
scientific article published on 17 August 2020
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
scientific article published on 01 September 2019
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. Reply
scientific article published on 01 March 2020
Angiotensin-neprilysin inhibition versus enalapril in heart failure
artículo científico publicado en 2014
Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial
artículo científico publicado en 2005
Anticoagulation therapy in heart failure and sinus rhythm: a systematic review and meta-analysis
artículo científico publicado en 2019
Anticoagulation, atherothrombosis, and heart failure: lessons from COMMANDER-HF and CORONA
artículo científico publicado en 2018
Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy
artículo científico publicado en 2013
Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale
artículo científico publicado en 2010
Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial
artículo científico publicado en 2013
Apparent Treatment-Resistant Hypertension Across the Spectrum of Heart Failure Phenotypes in the Swedish HF Registry
artículo científico publicado en 2022
Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial.
artículo científico publicado en 2007
Aspirin does not reduce the clinical benefits of the mineralocorticoid receptor antagonist eplerenone in patients with systolic heart failure and mild symptoms: an analysis of the EMPHASIS-HF study
artículo científico publicado en 2016
Aspirin inhibits the acute arterial and venous vasodilator response to captopril in patients with chronic heart failure
artículo científico publicado en 2005
Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medi
scientific article published on 30 March 2010
Assessment and prevalence of pulmonary oedema in contemporary acute heart failure trials: a systematic review
artículo científico publicado en 2015
Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow
artículo científico publicado en 2012
Assessment of long-term effects of irbesartan on heart failure with preserved ejection fraction as measured by the minnesota living with heart failure questionnaire in the irbesartan in heart failure with preserved systolic function (I-PRESERVE) tri
artículo científico
Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis.
artículo científico publicado en 2013
Association between mean systolic and diastolic blood pressure throughout the follow-up and cardiovascular events in acute myocardial infarction patients with systolic dysfunction and/or heart failure: an analysis from the High-Risk Myocardial Infar
artículo científico publicado en 2018
Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction
artículo científico publicado en 2014
Association is not causation: treatment effects cannot be estimated from observational data in heart failure
article
Association of Heart Rate and Outcomes in a Broad Spectrum of Patients With Chronic Heart Failure
article
Association of Lipoprotein(a) With Risk of Recurrent Ischemic Events Following Acute Coronary Syndrome: Analysis of the dal-Outcomes Randomized Clinical Trial.
artículo científico publicado en 2017
Association of QRS duration and outcomes after myocardial infarction: the VALIANT trial
artículo científico publicado en 2006
Association of diabetes and kidney function according to age and systolic function with the incidence of sudden cardiac death and non-sudden cardiac death in myocardial infarction survivors with heart failure
scientific article published on 02 September 2019
Associations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study
artículo científico publicado en 2011
Associations of chronic heart failure with outcome in acute ischaemic stroke patients who received systemic thrombolysis: analysis from VISTA.
artículo científico publicado en 2015
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
artículo científico publicado en 2019
Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program
artículo científico publicado en 2006
Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial
artículo científico publicado en 2010
Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century.
artículo científico
Atrial natriuretic factor inhibits ACTH stimulated aldosterone, but not cortisol, secretion in man
artículo científico publicado en 1988
Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians
artículo científico publicado en 2008
B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial
artículo científico publicado en 2019
B-type natriuretic peptides in chronic obstructive pulmonary disease: a systematic review
artículo científico publicado en 2017
Barcelona Bio-HF Calculator Version 2.0: incorporation of angiotensin II receptor blocker neprilysin inhibitor (ARNI) and risk for heart failure hospitalization
artículo científico publicado en 2017
Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease
artículo científico publicado en 2013
Baseline Characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
article
Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial
artículo científico publicado en 2018
Baseline characteristics and enrichment results of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial.
artículo científico publicado en 2018
Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme
artículo científico publicado en 2010
Baseline characteristics and treatment of patients in prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF).
artículo científico publicado en 2014
Baseline characteristics in the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE)
article
Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial
artículo científico publicado en 2013
Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF).
artículo científico publicado en 2013
Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials
artículo científico publicado en 2010
Baseline plasma NT-proBNP and clinical characteristics: results from the irbesartan in heart failure with preserved ejection fraction trial
artículo científico publicado en 2009
Benefits and safety of candesartan treatment in heart failure are independent of age: insights from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity programme
artículo científico publicado en 2008
Beta-blockers and heart failure in older people: reply
Beta-blockers and outcome in heart failure and atrial fibrillation: a meta-analysis
artículo científico publicado en 2013
Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials
artículo científico publicado en 2017
Beta-blockers, ventricular arrhythmias, and sudden death in heart failure: not as simple as it seems
artículo científico publicado en 2000
Biomarkers in heart failure: a clinical review.
scientific article published on 03 December 2008
Bisoprolol in patients with heart failure and moderate to severe chronic obstructive pulmonary disease: a randomized controlled trial.
artículo científico publicado en 2009
Blood pressure and mortality in patients with type 2 diabetes and a recent coronary event in the ELIXA trial
artículo científico publicado en 2020
Body Mass Index and Prognosis in Patients With Chronic Heart Failure
article
Body mass index and B-lines on lung ultrasonography in chronic and acute heart failure
artículo científico publicado en 2020
C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
artículo científico publicado en 2016
CAPTOPRIL, ENALAPRIL, AND BLOOD GLUCOSE
scientific article published in The Lancet
CCL21 is associated with fatal outcomes in chronic heart failure: data from CORONA and GISSI-HF trials
artículo científico publicado en 2013
CONSENSUS to EMPHASIS: the overwhelming evidence which makes blockade of the renin-angiotensin-aldosterone system the cornerstone of therapy for systolic heart failure.
artículo científico
Calcium Handling in the Failing Heart and SUMO — Weighing the Evidence
article
Calcium-antagonist controversy: the long and short of it?
artículo científico publicado en 1997
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure
artículo científico publicado en 2020
Cardiac and Extracardiac Abnormalities Detected by Cardiac Magnetic Resonance in a Post-Myocardial Infarction Cohort
Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both
Cardiorenal end points in a trial of aliskiren for type 2 diabetes
artículo científico publicado en 2012
Cardiovascular risk associated with serum potassium in the context of mineralocorticoid receptor antagonist use in patients with heart failure and left ventricular dysfunction
artículo científico publicado en 2020
Cardiovascular safety of albiglutide in the Harmony programme: a meta-analysis.
artículo científico publicado en 2015
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
scientific article published on 14 August 2019
Carvedilol reduces the costs of medical care in severe heart failure: an economic analysis of the COPERNICUS study applied to the United Kingdom.
artículo científico publicado en 2005
Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
artículo científico publicado en 2015
Chagas disease: still a neglected emergency?
scientific article published on 01 April 2020
Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease-Improving Global Outcomes (KDIGO) Controversies Conference.
artículo científico publicado en 2017
Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial
artículo científico publicado en 2017
Changes in N-terminal pro-B-type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: an analysis of the I-Preserve study.
artículo científico publicado en 2015
Changes in notions about heart failure.
artículo científico publicado en 2001
Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction
artículo científico publicado en 2005
Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM.
artículo científico publicado en 2006
Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response
artículo científico publicado en 2015
Chilling findings: the need for winter vigilance in heart failure.
artículo científico publicado en 2006
Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial
artículo científico publicado en 2016
Chronic obstructive pulmonary disease and cardiovascular risk: Insights from the NAVIGATOR trial
scholarly article by Pedro G.M. de Barros e Silva et al published October 2014 in International Journal of Cardiology
Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
artículo científico publicado en 2009
Circulating Cardiac Troponin I Levels Measured by a Novel Highly Sensitive Assay in Acute Decompensated Heart Failure: Insights From the ASCEND-HF Trial
artículo científico publicado en 2018
Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
artículo científico publicado en 2015
Circumstances and outcomes of sudden unexpected death in patients with high-risk myocardial infarction: implications for prevention
artículo científico publicado en 2011
Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes: Implications for the Cardiovascular Disease Specialist
artículo científico publicado en 2018
Clinical Characteristics and Outcomes of Patients With Coronary Artery Disease and Angina: Analysis of the Irbesartan in Patients With Heart Failure and Preserved Systolic Function Trial
artículo científico
Clinical Trials Report: Cardiovascular & Renal: Ongoing and planned clinical trials in chronic heart failure and left ventricular dysfunction
Clinical Trials Series
Clinical Trials Update AHA Congress 2010.
artículo científico publicado en 2011
Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ej
artículo científico
Clinical benefit of eplerenone in patients with mild symptoms of systolic heart failure already receiving optimal best practice background drug therapy: analysis of the EMPHASIS-HF study
artículo científico publicado en 2013
Clinical benefits of eplerenone in patients with systolic heart failure and mild symptoms when initiated shortly after hospital discharge: analysis from the EMPHASIS-HF trial
artículo científico publicado en 2015
Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) Programme
article by Athar A. Badar et al published February 2015 in European Journal of Heart Failure
Clinical characteristics and outcomes of young and very young adults with heart failure: The CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity).
artículo científico publicado en 2013
Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program
artículo científico publicado en 2006
Clinical development of pharmacologic agents for acute heart failure syndromes: a proposal for a mechanistic translational phase
artículo científico publicado en 2010
Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study
artículo científico publicado en 2005
Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document
artículo científico publicado en 2013
Clinical outcomes according to QRS duration and morphology in the Eplerenone in Mild Patients: Hospitalization and SurvIval Study in Heart Failure (EMPHASIS-HF).
artículo científico publicado en 2015
Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I-PRESERVE) trial.
artículo científico publicado en 2016
Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) Program
artículo científico publicado en 2008
Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trial
artículo científico publicado en 2015
Clinical practice. Systolic heart failure.
artículo científico publicado en 2010
Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry
artículo científico publicado en 2020
Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward
scientific article published on March 2010
Clinical trials update from the European Society of Cardiology Congress in Vienna, 2007: PROSPECT, EVEREST, ARISE, ALOFT, FINESSE, Prague-8, CARESS in MI and ACUITY.
artículo científico publicado en 2007
Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure).
artículo científico publicado en 2010
Cognitive Impairment and Heart Failure: Systematic Review and Meta-Analysis.
artículo científico publicado en 2017
Combined Free Light Chains Are Novel Predictors of Prognosis in Heart Failure.
artículo científico publicado en 2015
Combined neprilysin and renin-angiotensin system inhibition in heart failure with reduced ejection fraction: a meta-analysis.
artículo científico publicado en 2016
Comorbidities and differential diagnosis in heart failure with preserved ejection fraction
artículo científico
Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Hypertension on Clinical End Points: A Cohort Study
scientific article published on 26 July 2012
Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trial
artículo científico publicado en 2014
Comparing LCZ696 with enalapril according to baseline risk using the MAGGIC and EMPHASIS-HF risk scores: an analysis of mortality and morbidity in PARADIGM-HF.
artículo científico publicado en 2015
Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction
artículo científico publicado en 2020
Comparison of Time-to-First Event and Recurrent Event Methods in Randomized Clinical Trials.
artículo científico publicado en 2018
Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).
artículo científico publicado en 2002
Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction
artículo científico publicado en 2014
Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitus
artículo científico publicado en 2008
Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
scientific article published on 04 June 2020
Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy
artículo científico publicado en 2017
Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure
artículo científico publicado en 2017
Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
artículo científico publicado en 2016
Correction: Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry
artículo científico publicado en 2018
Corrigendum to ‘Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved’ [Eur J Heart Fail2014;16:33-40]
scholarly article published in European Journal of Heart Failure
Corrigendum to ‘Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial’ [Eur J Heart Fail2009;11:795-801]
scholarly article published in European Journal of Heart Failure
Corrigendum to ‘ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008’ [Eur Heart J 2008;29:2388-2442 and Eur J Heart Fail 2008;10:933-989]
scholarly article published in European Journal of Heart Failure
Corrigendum to ‘ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008’ [Eur Heart J 2008;29:2388-2442 and Eur J Heart Fail 2008;10:933-989]
scholarly article published in European Journal of Heart Failure
Corrigendum to ‘ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008’[Eur Heart J 2008;29:2388–2442 and Eur J Heart Fail 2008;10:933–989]
scholarly article published in European Heart Journal
Corrigendum to “Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker” [European Journal of Heart Failure 9/4 (2007) 429-434]
scholarly article published in European Journal of Heart Failure
Cost effectiveness of invasive strategy in unstable coronary disease--what are we waiting for?
artículo científico publicado en 2002
Cost effectiveness of lowering cholesterol. Study greatly underestimates the cost effectiveness of statin treatment.
artículo científico publicado en 1996
Cost-Effectiveness Analysis of Natriuretic Peptide Testing and Specialist Management in Patients with Suspected Acute Heart Failure
artículo científico publicado en 2017
Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction
artículo científico publicado en 2016
Cost-effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health-economic analysis of DAPA-HF
artículo científico publicado en 2020
Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms
artículo científico publicado en 2014
Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction.
artículo científico publicado en 2017
Covariate adjusted reanalysis of the I-Preserve trial
artículo científico publicado en 2020
Current evidence on treatment of patients with chronic systolic heart failure and renal insufficiency: practical considerations from published data
artículo científico publicado en 2013
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy
scientific article published on August 2010
Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease
scientific article published on 06 March 2020
Dapagliflozin and Diuretic Use in Patients with Heart Failure and Reduced Ejection Fraction in DAPA-HF
artículo científico publicado en 2020
Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HF
artículo científico publicado en 2020
Dapagliflozin in Patients with Chronic Kidney Disease
artículo científico publicado en 2020
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
artículo científico publicado en 2019
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. Reply
scientific article published on 01 March 2020
Darbepoetin Alfa in Systolic Heart Failure
artículo científico publicado en 2013
Darbepoetin alfa impact on health status in diabetes patients with kidney disease: a randomized trial
artículo científico publicado en 2011
Data-Driven Approach to Identify Subgroups of Heart Failure With Reduced Ejection Fraction Patients With Different Prognoses and Aldosterone Antagonist Response Patterns
scientific article published on 01 July 2018
Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program
artículo científico
Declining Risk of Sudden Death in Heart Failure
artículo científico publicado en 2017
Declining Risk of Sudden Death in Heart Failure
artículo científico publicado en 2017
Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fraction
artículo científico publicado en 2016
Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial
artículo científico publicado en 2009
Determining the most appropriate components for a composite clinical trial outcome
artículo científico publicado en 2008
Developing therapies for heart failure with preserved ejection fraction: current state and future directions
artículo científico publicado en 2014
Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements?
artículo científico publicado en 2012
Diabetes, left ventricular systolic dysfunction, and chronic heart failure
artículo científico publicado en 2008
Diabetic cardiomyopathy
artículo científico publicado en 2018
Diagnosing heart failure with preserved ejection fraction - what's the score?
artículo científico publicado en 2020
Diagnostic tests, drug prescriptions, and follow-up patterns after incident heart failure: A cohort study of 93,000 UK patients.
artículo científico publicado en 2019
Dichotomous Relationship Between Age and 30-Day Death or Rehospitalization in Heart Failure Patients Admitted With Acute Decompensated Heart Failure: Results From the ASCEND-HF Trial.
artículo científico publicado en 2016
Differences in arterial compliance, microvascular function and venous capacitance between patients with heart failure and either preserved or reduced left ventricular systolic function
article
Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and Women
scientific article published on 01 January 2019
Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure
artículo científico publicado en 2013
Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (
article
Discharge rates for suspected acute coronary syndromes: Authors' reply.
artículo científico publicado en 2004
Discordant short- and long-term outcomes associated with diabetes in patients with heart failure: importance of age and sex: a population study of 5.1 million people in Scotland
scientific article published on 01 November 2008
Disease Management Programs in Cardiology
Do We Need Clinical Events Committees to Adjudicate End Points?
artículo científico publicado en 2020
Do countries or hospitals with longer hospital stays for acute heart failure have lower readmission rates?: Findings from ASCEND-HF.
artículo científico
Do statins reduce the risk of myocardial infarction in patients with heart failure? A pooled individual-level reanalysis of CORONA and GISSI-HF.
artículo científico publicado en 2015
Documento de Consenso de Expertos sobre bloqueadores de los receptores ß-adrenérgicos
scientific article published on 01 January 2005
Documento de Consenso de Expertos sobre el uso de inhibidores de la enzima de conversión de la angiotensina en la enfermedad cardiovascular
Does aspirin reduce the benefit of an angiotensin-converting enzyme inhibitor? Choosing between the Scylla of observational studies and the Charybdis of subgroup analysis
artículo científico publicado en 2006
Does luminol chemiluminescence detect free radical scavengers?
⬇️
artículo científico publicado el 1 de junio de 1995
Dual Renin-Angiotensin System Blockade in Heart Failure
Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine I
article
Dual renin-angiotensin system blockade and kidney disease.
artículo científico publicado en 2009
Dynamic changes and prognostic value of pulmonary congestion by lung ultrasound in acute and chronic heart failure: a systematic review
artículo científico publicado en 2017
Dysglycemia and Heart Failure Hospitalization
EARTH: Endothelin A Receptor Antagonist Trial in Heart Failure
ECG--still the best for selecting patients for CRT.
artículo científico publicado en 2013
EFFECT OF DIARRHOEA ON A PATIENT TAKING CAPTOPRIL
artículo científico publicado en 1985
EMPA-REG – the “diuretic hypothesis”
article
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology
artículo científico publicado en 2008
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology
artículo científico publicado en 2008
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the
artículo científico publicado en 2012
ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD.
artículo científico publicado en 2017
EURObservational Research Programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM.
artículo científico publicado en 2014
Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction
artículo científico publicado en 2019
Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial
artículo científico
Economic evaluation of the impact of nicorandil in angina (IONA) trial.
artículo científico publicado en 2006
Economic factors associated with antithrombotic treatments for stroke prevention in patients with atrial fibrillation
Economics of chronic heart failure.
artículo científico publicado en 2001
Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect
artículo científico publicado en 2017
Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy
⬇️
artículo científico publicado en 2020
Effect of Dapagliflozin in Patients With HFrEF Treated With Sacubitril/Valsartan: The DAPA-HF Trial
scientific article published on 05 July 2020
Effect of Dapagliflozin on Outpatient Worsening of Patients with Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HF
scientific article published on 04 September 2020
Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes
artículo científico publicado en 2020
Effect of Neladenoson Bialanate on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial
scientific article published on 01 June 2019
Effect of Rosuvastatin on Fatigue in Patients With Heart Failure
article
Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEF
artículo científico publicado en 2020
Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure
artículo científico publicado en 2017
Effect of adrenomedullin on the production of endothelin-1 and on its vasoconstrictor action in resistance arteries: evidence for a receptor-specific functional interaction in patients with heart failure
artículo científico publicado en 2001
Effect of adrenomedullin on the production of endothelin-1 and on its vasoconstrictor action in resistance arteries: evidence for a receptor-specific functional interaction in patients with heart failure
article
Effect of aliskiren in patients with heart failure according to background dose of ACE inhibitor: a retrospective analysis of the Aliskiren Observation of Heart Failure Treatment (ALOFT) trial
artículo científico publicado en 2011
Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction
artículo científico publicado en 2007
Effect of aspirin on vasodilation to bradykinin and substance P in patients with heart failure treated with ACE inhibitor
artículo científico publicado en 2002
Effect of candesartan on New York Heart Association functional class. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme
artículo científico publicado en 2004
Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program
artículo científico publicado en 2004
Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas
artículo científico publicado en 2006
Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)
artículo científico publicado en 2020
Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction
artículo científico publicado en 2018
Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity: Insight from the EMPHASIS-HF trial
artículo científico publicado en 2017
Effect of nateglinide on the incidence of diabetes and cardiovascular events
artículo científico publicado en 2010
Effect of neprilysin inhibition on renal function in patients with type 2 diabetes and chronic heart failure who are receiving target doses of inhibitors of the renin-angiotensin system: a secondary analysis of the PARADIGM-HF trial
artículo científico publicado en 2018
Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial
artículo científico publicado en 2013
Effect of rosuvastatin on repeat heart failure hospitalizations: the CORONA Trial (Controlled Rosuvastatin Multinational Trial in Heart Failure).
artículo científico publicado en 2014
Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).
artículo científico publicado en 2018
Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial.
artículo científico publicado en 2017
Effect of single and dual renin-angiotensin blockade on stroke in patients with and without diabetes in VALIANT
scientific article published on 09 May 2016
Effect of socioeconomic deprivation on the population risk of incident heart failure hospitalisation: An analysis of the Renfrew/Paisley Study
article
Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials
artículo científico publicado en 2012
Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients
artículo científico publicado en 2015
Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction
article
Effect of valsartan on kidney outcomes in people with impaired glucose tolerance
artículo científico publicado en 2017
Effect of valsartan on the incidence of diabetes and cardiovascular events
artículo científico publicado en 2010
Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial
artículo científico publicado en 2019
Effects of Neutral Endopeptidase (Neprilysin) Inhibition on the Response to Other Vasoactive Peptides in Small Human Resistance Arteries: Studies with Thiorphan and Omapatrilat
article
Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF
artículo científico publicado en 2019
Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney Disease
artículo científico publicado en 2018
Effects of Sacubitril/Valsartan in the PARADIGM-HF Trial (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) According to Background Therapy
artículo científico
Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEF
scientific article published on 01 February 2019
Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction
artículo científico publicado en 2020
Effects of Sacubitril/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure: A Secondary Analysis of the PARADIGM-HF Trial
artículo científico publicado en 2018
Effects of Vildagliptin on Ventricular Function in Patients With Type 2 Diabetes Mellitus and Heart Failure: A Randomized Placebo-Controlled Trial
artículo científico publicado en 2017
Effects of a Novel Nitroxyl Donor in Acute Heart Failure: The STAND-UP AHF Study
scientific article published on 24 November 2020
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
artículo científico publicado en 2017
Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker
artículo científico publicado en 2006
Effects of apixaban compared with warfarin as gain in event-free time - a novel assessment of the results of the ARISTOTLE trial
scientific article published on 07 November 2019
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial
artículo científico publicado en 2003
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial
artículo científico publicado en 2003
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
artículo científico publicado en 2003
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme
artículo científico publicado en 2003
Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure
artículo científico publicado en 2005
Effects of dalcetrapib in patients with a recent acute coronary syndrome
artículo científico publicado en 2012
Effects of dapagliflozin in DAPA-HF according to background heart failure therapy
artículo científico publicado en 2020
Effects of renin–angiotensin system blockers on outcomes from COVID-19: a systematic review and meta-analysis of randomized controlled trials
artículo científico publicado en 2023
Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis
artículo científico publicado en 2009
Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial
artículo científico publicado en 2008
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials
artículo científico publicado en 2007
Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure
artículo científico publicado en 2008
Effects of the xanthine oxidase system on cardiac function in anaesthetised rats
scientific article published on 01 September 1993
Effects of xamoterol in acute myocardial infarction: blood pressure, heart rate, arrhythmias and early clinical course
artículo científico publicado en 1991
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF
artículo científico publicado en 2019
Efficacy and Safety of Novel Oral Anticoagulants in Patients With Atrial Fibrillation and Heart Failure: A Meta-Analysis.
artículo científico publicado en 2016
Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF.
artículo científico publicado en 2015
Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity (CHARM) programme
artículo científico publicado en 2010
Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial.
artículo científico publicado en 2012
Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation.
artículo científico publicado en 2013
Efficacy and safety of digoxin in patients with heart failure and reduced ejection fraction according to diabetes status: An analysis of the Digitalis Investigation Group (DIG) trial.
artículo científico publicado en 2016
Efficacy and safety of sodium-glucose co-transporter 2 inhibition according to left ventricular ejection fraction in DAPA-HF
artículo científico publicado en 2020
Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in He
artículo científico publicado en 2008
Efficacy of Sacubitril/Valsartan Relative to a Prior Decompensation: The PARADIGM-HF Trial
artículo científico publicado en 2016
Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction
artículo científico publicado en 2019
Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial
artículo científico publicado en 2016
Electrical cardioversion for atrial fibrillation: outcomes in "real-life" clinical practice.
artículo científico publicado en 2001
Elevated serum and monocyte tumour necrosis factor alpha in patients with congestive heart failure
artículo científico publicado en 1999
Elevation in high-sensitivity troponin T in heart failure and preserved ejection fraction and influence of treatment with the angiotensin receptor neprilysin inhibitor LCZ696.
artículo científico
Employment status at time of first hospitalization for heart failure is associated with a higher risk of death and rehospitalization for heart failure.
artículo científico publicado en 2017
End of the Road for Vagus Nerve Stimulation? ∗
Endothelin receptor antagonism in patients with chronic heart failure
scientific article published on 01 July 2000
Endothelin-1 has haemodynamic effects at pathophysiological concentrations in patients with left ventricular dysfunction.
artículo científico publicado en 1998
Epidemiology of Heart Failure and Left Ventricular Systolic Dysfunction after Acute Myocardial Infarction: Prevalence, Clinical Characteristics, and Prognostic Importance
artículo científico publicado en 2006
Epidemiology of heart failure and left ventricular dysfunction after acute myocardial infarction.
artículo científico publicado en 2006
Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study
artículo científico publicado en 2012
Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF).
artículo científico publicado en 2012
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
⬇️
artículo científico publicado el 14 de noviembre de 2010
Eplerenone in patients with systolic heart failure and mild symptoms: analysis of repeat hospitalizations
artículo científico
Erratum to "Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency" [Eur J Heart Fail 2016;18:482-489].
artículo científico publicado en 2016
Erratum to: SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
artículo científico publicado en 2016
Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes
article
Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis
scientific article published on 01 December 2018
Estimated Long-Term Survival With Eplerenone
scientific article published on 01 May 2019
Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials
scientific article published on 21 May 2020
Estimating the Long-Term Treatment Benefits of Sacubitril–Valsartan
article
Estimating the impact of stroke unit care in a whole population: an epidemiological study using routine data
artículo científico publicado en 2010
European Society of Cardiology - Acute Cardiovascular Care Association position paper on safe discharge of acute heart failure patients from the emergency department
artículo científico publicado en 2016
European Society of Cardiology-Acute Cardiovascular Care Association Position paper on acute heart failure: A call for interdisciplinary care
artículo científico
Evaluating dyspnoea in acute heart failure: progress at last!
artículo científico publicado en 2010
Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study
artículo científico publicado en 2010
Evaluation of increased adherence and cost savings of an employer value-based benefits program targeting generic antihyperlipidemic and antidiabetic medications
scientific article published on 01 February 2014
Evaluation of the functional status questionnaire in heart failure: a sub-study of the second cardiac insufficiency bisoprolol survival study (CIBIS-II).
artículo científico publicado en 2011
Event Rates in Trials of Patients With Type 2 Diabetes
scientific article published in The Journal of the American Medical Association
Evidence for enhanced free radical activity in chronic congestive heart failure secondary to coronary artery disease
article
Evidence for oxidative stress in unstable angina
⬇️
artículo científico publicado el 1 de noviembre de 1992
Evidence-Based Therapy and Its Association With Workforce Detachment After First Hospitalization for Heart Failure
artículo científico publicado en 2017
Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation
scientific article published on April 2011
Expert consensus document: Echocardiography and lung ultrasonography for the assessment and management of acute heart failure
artículo científico publicado en 2017
Expert consensus document: Reporting checklist for quantification of pulmonary congestion by lung ultrasound in heart failure
scientific article published on 19 June 2019
Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
article published in 2006
Extracellular Matrix Turnover and Inflammatory Markers Independently Predict Functional Status and Outcome in Chronic Heart Failure
article
Factors Associated With Noncompletion During the Run-In Period Before Randomization and Influence on the Estimated Benefit of LCZ696 in the PARADIGM-HF Trial
artículo científico
Factors Associated With Outcome in Heart Failure With Preserved Ejection Fraction
article
Failing ageing hearts
artículo científico publicado en 2001
Falling Cardiovascular Mortality in Heart Failure With Reduced Ejection Fraction and Implications for Clinical Trials.
artículo científico
Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALsartan In Acute myocardial iNfarcTion Trial (VALIANT).
artículo científico publicado en 2010
Fatigue as a Predictor of Outcome in Patients With Heart Failure
article
Feasibility/eligibility of T-wave alternans testing in patients with heart failure: should we rethink our current modus operandi?: reply
From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5)
artículo científico publicado en 2019
Frusemide pretreatment blunts the inhibition of renal tubular sodium reabsorption by ANF in man
artículo científico publicado en 1988
Galectin-3 and cardiac function in survivors of acute myocardial infarction.
artículo científico
Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
artículo científico publicado en 2012
Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial.
artículo científico publicado en 2009
Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis
artículo científico publicado en 2012
Gender and survival: a population-based study of 201,114 men and women following a first acute myocardial infarction
article
Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure
scientific article published on 09 January 2020
Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial).
artículo científico publicado en 2016
Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial
artículo científico publicado en 2006
Geographic variations in the PARADIGM-HF heart failure trial.
artículo científico publicado en 2016
Glucagon-Like Peptide 1 Receptor Agonists and Heart Failure: The Need for Further Evidence Generation and Practice Guidelines Optimization
scientific article published on 21 September 2020
Growth differentiation factor-15 is not modified by sacubitril/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM-HF trial
artículo científico publicado en 2018
Gut feelings about heart failure.
artículo científico publicado en 2014
Guía ESC 2016 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración con la EACTS
Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica
Guía de práctica clínica de la ESC sobre diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica 2012
HEAAL: the final chapter in the story of angiotensin receptor blockers in heart failure--lessons learnt from a decade of trials
artículo científico publicado en 2010
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
artículo científico publicado en 2014
Harmony Outcomes: A randomized, double-blind, placebo-controlled trial of the effect of albiglutide on major cardiovascular events in patients with type 2 diabetes mellitus-Rationale, design, and baseline characteristics
artículo científico publicado en 2018
Health-Related Quality of Life Outcomes in PARADIGM-HF.
artículo científico publicado en 2017
Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial
scientific article published on 10 July 2019
Heart Failure
Heart Failure
Heart Failure After Acute Myocardial Infarction
article
Heart Failure With Preserved Ejection Fraction in the Young
artículo científico publicado en 2018
Heart Failure in Young Adults Is Associated With High Mortality: A Contemporary Population-Level Analysis.
artículo científico publicado en 2017
Heart Failure: Epidemiology, Pathophysiology, and Management of Heart Failure in Diabetes Mellitus
artículo científico publicado en 2017
Heart failure
artículo científico publicado en 2005
Heart failure and chronic obstructive pulmonary disease the quandary of Beta-blockers and Beta-agonists
artículo científico publicado en 2011
Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology
artículo científico publicado en 2009
Heart failure and chronic obstructive pulmonary disease: lung function test interpretation: reply
scholarly article by Nathaniel M. Hawkins et al published 25 May 2009 in European Journal of Heart Failure
Heart failure and socioeconomic status: accumulating evidence of inequality
artículo científico publicado en 2012
Heart failure care in low- and middle-income countries: a systematic review and meta-analysis
artículo científico publicado en 2014
Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial.
artículo científico publicado en 2010
Heart failure in 2011: Heart failure therapy--technology to the fore.
artículo científico publicado en 2012
Heart failure in a cold climate. Seasonal variation in heart failure-related morbidity and mortality.
artículo científico publicado en 2002
Heart failure in younger patients: the Meta-analysis Global Group in Chronic Heart Failure (MAGGIC)
artículo científico publicado en 2014
Heart failure management programs reduce readmissions and prolong survival
scientific article published on 01 June 2005
Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registry
artículo científico publicado en 2005
Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum
artículo científico publicado en 2018
Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial.
artículo científico publicado en 2008
Heart failure with preserved left ventricular systolic function: a hospital cohort study
artículo científico publicado en 2005
Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis
artículo científico publicado en 2004
Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas
scientific article published on 10 December 2018
Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored
artículo científico publicado en 2014
Heart failure: are we neglecting the silent majority?
artículo científico publicado en 2007
Heart failure: we need more trials in typical patients
scientific article published on 01 May 2000
Hemoglobin Stability in Patients With Anemia, CKD, and Type 2 Diabetes: An Analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) Placebo Arm
article
Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial
artículo científico publicado en 2020
High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial
artículo científico publicado en 2008
High-sensitivity C-reactive protein in acute heart failure: insights from the ASCEND-HF trial.
artículo científico publicado en 2014
High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
artículo científico publicado en 2013
High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin
artículo científico publicado en 2013
History of atrial fibrillation as a risk factor in patients with heart failure and preserved ejection fraction
artículo científico
Hospital-at-home care for CHF—verdict, 'not proven'
artículo científico publicado en 2010
How Do SGLT2 (Sodium-Glucose Cotransporter 2) Inhibitors and GLP-1 (Glucagon-Like Peptide-1) Receptor Agonists Reduce Cardiovascular Outcomes?: Completed and Ongoing Mechanistic Trials
scientific article published on 30 January 2020
How robust are clinical trials in heart failure?
artículo científico publicado en 2016
How should we optimize cardiac resynchronization therapy?
artículo científico publicado en 2008
How small is too small? A systematic review of center volume and outcome after cardiac transplantation
artículo científico publicado en 2012
Hyperglycaemia, ejection fraction and the risk of heart failure or cardiovascular death in patients with type 2 diabetes and a recent acute coronary syndrome
scientific article published on 25 March 2020
Hyporesponsiveness to Darbepoetin Alfa in Patients With Heart Failure and Anemia in the RED-HF Study (Reduction of Events by Darbepoetin Alfa in Heart Failure): Clinical and Prognostic Associations
artículo científico publicado en 2018
Hypotension during hospitalization for acute heart failure is independently associated with 30-day mortality: findings from ASCEND-HF
artículo científico publicado en 2014
IGFBP7 (Insulin-Like Growth Factor-Binding Protein-7) and Neprilysin Inhibition in Patients With Heart Failure
artículo científico publicado en 2018
Impact of Body Mass Index on the Accuracy of N-Terminal Pro-Brain Natriuretic Peptide and Brain Natriuretic Peptide for Predicting Outcomes in Patients With Chronic Heart Failure and Reduced Ejection Fraction: Insights From the PARADIGM-HF Study (Pr
artículo científico publicado en 2016
Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure
scientific article published on 01 December 2019
Impact of baseline physical activity and diet behavior on metabolic syndrome in a pharmaceutical trial: results from NAVIGATOR.
artículo científico publicado en 2014
Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure
artículo científico publicado en 2005
Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme
artículo científico publicado en 2008
Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia
Impact of eplerenone on major cardiovascular outcomes in patients with systolic heart failure according to baseline heart rate
artículo científico publicado en 2019
Impact of erythropoiesis-stimulating agents on morbidity and mortality in patients with heart failure: an updated, post-TREAT meta-analysis.
artículo científico publicado en 2010
Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure
artículo científico publicado en 2008
Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with heart failure and left-ventricular systolic dysfunction: an individual patient-level meta-analysis of three randomized-controlled trials
scientific article published on 27 September 2018
Impact of systolic blood pressure on the safety and tolerability of initiating and up-titrating sacubitril/valsartan in patients with heart failure and reduced ejection fraction: insights from the TITRATION study.
artículo científico publicado en 2017
Impaired left atrial function in heart failure with preserved ejection fraction.
artículo científico publicado en 2014
Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
artículo científico publicado en 2013
Impaired vascular responsiveness to nitric oxide in renal transplant recipients
artículo científico publicado en 1999
Importance of Clinical Worsening of Heart Failure Treated in the Outpatient Setting: Evidence From the Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF).
artículo científico
Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failure.
artículo científico publicado en 2016
Importance of heart failure as a cause of death. Changing contribution to overall mortality and coronary heart disease mortality in Scotland 1979-1992.
artículo científico publicado en 1998
Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS-II) trial
artículo científico publicado en 2010
Improving outcomes in heart failure: a personal perspective
Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program
artículo científico publicado en 2007
Incidence and prevalence of unrecognized myocardial infarction in people with diabetes: a substudy of the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes (RECORD) study
artículo científico publicado en 2011
Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research tri
artículo científico publicado en 2013
Incidence, Predictors, and Outcomes Associated With Hypotensive Episodes Among Heart Failure Patients Receiving Sacubitril/Valsartan or Enalapril: The PARADIGM-HF Trial (Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor With Angiot
artículo científico publicado en 2018
Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: result
artículo científico
Income Inequality and Outcomes in Heart Failure: A Global Between-Country Analysis
scientific article published on 06 February 2019
Income level and inequality as complement to geographical differences in cardiovascular trials
scientific article published on 01 September 2019
Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide
artículo científico publicado en 2007
Increased mortality after dronedarone therapy for severe heart failure
artículo científico publicado en 2008
Increased mortality with elevated plasma endothelin-1 in acute heart failure: an ASCEND-HF biomarker substudy
artículo científico publicado en 2015
Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney disease
artículo científico publicado en 2015
Increases in Natriuretic Peptides Precede Heart Failure Hospitalization in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus
artículo científico publicado en 2017
Increasing awareness and perception of heart failure in Europe and improving care--rationale and design of the SHAPE Study
artículo científico publicado en 2004
Incremental value of echocardiographic assessment beyond clinical evaluation for prediction of death and development of heart failure after high-risk myocardial infarction
article
Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trial
article
Independent Prognostic Value of Serum Soluble ST2 Measurements in Patients With Heart Failure and a Reduced Ejection Fraction in the PARADIGM-HF Trial (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in
artículo científico publicado en 2018
Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology
artículo científico publicado en 2009
Inflammatory cytokines in chronic heart failure: interleukin-8 is associated with adverse outcome. Results from CORONA.
artículo científico publicado en 2013
Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Fai
artículo científico
Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure
article
Influence of Sacubitril/Valsartan (LCZ696) on 30-Day Readmission After Heart Failure Hospitalization
artículo científico publicado en 2016
Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients
artículo científico publicado en 2005
Influence of hospitalization for cardiovascular versus noncardiovascular reasons on subsequent mortality in patients with chronic heart failure across the spectrum of ejection fraction
artículo científico
Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction
artículo científico publicado en 2014
Influenza Vaccination in Patients With Chronic Heart Failure: The PARADIGM-HF Trial
artículo científico publicado en 2015
Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens.
artículo científico publicado en 2016
Insufficient reduction in heart rate during hospitalization despite beta-blocker treatment in acute decompensated heart failure: insights from the ASCEND-HF trial
artículo científico publicado en 2016
Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction
scientific article published on 04 July 2019
Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: evidence from a 37,229 patient meta-analysis.
artículo científico publicado en 2011
Inter-individual variability in atrasentan exposure partly explains variability in kidney protection and fluid retention responses: a post-hoc analysis of the SONAR trial
artículo científico publicado en 2020
Interactions between left ventricular ejection fraction, sex and effect of neurohumoral modulators in heart failure
artículo científico publicado en 2020
Interleukin-21 – A biomarker of importance in predicting myocardial function following acute infarction?
scientific article published on 27 June 2012
Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA).
artículo científico publicado en 2010
International Variation in Outcomes Among People with Cardiovascular Disease or Cardiovascular Risk Factors and Impaired Glucose Tolerance: Insights from the NAVIGATOR Trial.
artículo científico
International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction
artículo científico publicado en 2014
Interventions to prevent readmission for congestive heart failure
scientific article published on 01 June 2004
Intravenous Iron Dosing and Infection Risk in Patients on Hemodialysis: A Prespecified Secondary Analysis of the PIVOTAL Trial
scientific article published on 06 April 2020
Intravenous Iron in Patients Undergoing Maintenance Hemodialysis
article published in 2018
Irbesartan in patients with heart failure and preserved ejection fraction
artículo científico publicado en 2008
Iron deficiency: an ominous sign in patients with systolic chronic heart failure
artículo científico publicado en 2010
Iron status in patients with chronic heart failure
artículo científico publicado en 2012
Is a reduction in albuminuria associated with renal and cardiovascular protection? A post hoc analysis of the ALTITUDE trial.
artículo científico publicado en 2015
Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysis
artículo científico publicado en 2015
Is microvolt T-wave alternans the answer to risk stratification in heart failure?
artículo científico publicado en 2007
Is the pregnancy hormone relaxin also a vasodilator peptide secreted by the heart?
artículo científico publicado en 2002
It is BEAUTIFUL we should be concerned about, not SIGNIFY: is ivabradine less effective in ischaemic compared with non-ischaemic LVSD?
artículo científico
Known and missing left ventricular ejection fraction and survival in patients with heart failure: a MAGGIC meta-analysis report
article
Large streamlined trials in cardiovascular disease
artículo científico publicado en 2014
Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo Study
artículo científico publicado en 2008
Left ventricular dyssynchrony in patients with heart failure and preserved ejection fraction.
artículo científico publicado en 2013
Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trial
artículo científico
Lessons from the TOPCAT Trial
article
Lessons in Uncertainty and Humility - Clinical Trials Involving Hypertension.
artículo científico publicado en 2016
Letter by MacDonald et al Regarding Article, "Catheter Ablation of Atrial Fibrillation"
Letters to the Editor
artículo científico publicado en 1999
Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart Failure
artículo científico publicado en 2017
Lipid-modifying therapies and risk of pancreatitis: a meta-analysis
artículo científico publicado en 2012
Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program
artículo científico publicado en 2009
Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF.
artículo científico publicado en 2015
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
artículo científico publicado en 2015
Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the ENABLE Trials
artículo científico publicado en 2017
Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew–Paisley study)
scientific article published on 23 September 2005
Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial
artículo científico publicado en 2004
Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: The VALIANT experience
Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people.
artículo científico publicado en 2009
Longitudinal and circumferential strain rate, left ventricular remodeling, and prognosis after myocardial infarction
artículo científico publicado en 2010
Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF.
artículo científico publicado en 2015
Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.
artículo científico publicado en 2015
Losing ALTITUDE? How should ASTRONAUT launch into ATMOSPHERE.
artículo científico publicado en 2013
Low YKL-40 in chronic heart failure may predict beneficial effects of statins: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA).
artículo científico publicado en 2016
Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failure
artículo científico publicado en 2005
Lung Ultrasound in Acute Heart Failure: Prevalence of Pulmonary Congestion and Short- and Long-Term Outcomes
artículo científico publicado en 2019
Lung ultrasound: monitoring congestion in patients with heart failure
scientific article published on 08 November 2019
MRAs in Elderly HF Patients: Individual Patient-Data Meta-Analysis of RALES, EMPAHSIS-HF, and TOPCAT
artículo científico publicado en 2019
Making Sense of Statistics in Clinical Trial Reports: Part 1 of a 4-Part Series on Statistics for Clinical Trials
artículo científico publicado en 2015
Making sense of SENIORS.
artículo científico publicado en 2005
Mapping the emergence of heart disease in a black, urban population in Africa: the Heart of Soweto Study.
artículo científico publicado en 2006
Mean BMI, visit-to-visit BMI variability and BMI changes during follow-up in patients with acute myocardial infarction with systolic dysfunction and/or heart failure: insights from the High-Risk Myocardial Infarction Initiative
scientific article published on 05 April 2019
Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Stud
artículo científico publicado en 2017
Mechanisms and predictors of mitral regurgitation after high-risk myocardial infarction
artículo científico publicado en 2012
Medical management of advanced heart failure
Meta-Analysis of Large-Scale Randomized Trials to Determine the Effectiveness of Inhibition of the Renin-Angiotensin Aldosterone System in Heart Failure
artículo científico publicado en 2015
Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial.
artículo científico publicado en 2013
Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease
artículo científico publicado en 2019
Methodology of a reevaluation of cardiovascular outcomes in the RECORD trial: study design and conduct
artículo científico publicado en 2013
Microvascular Disease in Patients With Diabetes With Heart Failure and Reduced Ejection Versus Preserved Ejection Fraction
artículo científico publicado en 2019
Microvascular complications in diabetes patients with heart failure and reduced ejection fraction-insights from the Beta-blocker Evaluation of Survival Trial
artículo científico publicado en 2018
Microvascular obstruction remains a portent of adverse remodeling in optimally treated patients with left ventricular systolic dysfunction after acute myocardial infarction.
artículo científico publicado en 2010
Microvolt T-Wave Alternans Testing Has No Role at Present in Guiding Therapy for Patients at High Risk of Ventricular Arrhythmias
artículo científico publicado en 2012
Microvolt T-wave alternans testing in patients recently hospitalized with decompensated heart failure
artículo científico publicado en 2013
Microvolt T-wave alternans testing should be used to guide arrhythmic therapy in heart failure patients: reply
Mind the Gap: Current Challenges and Future State of Heart Failure Care
artículo científico publicado en 2017
Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction
scientific article published on 08 January 2020
Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice
artículo científico publicado en 2012
Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function
artículo científico publicado en 2007
Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial
artículo científico publicado en 2010
Monocyte chemoattractant protein-1: a dichotomous role in cardiac remodeling following acute myocardial infarction in man?
artículo científico publicado en 2010
More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure
artículo científico publicado en 2001
Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials
artículo científico publicado en 2004
Mortality following a cardiovascular or renal event in patients with type 2 diabetes in the ALTITUDE trial.
artículo científico publicado en 2015
Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials.
artículo científico publicado en 2004
Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry
artículo científico publicado en 2018
Myocardial Infarction in Heart Failure With Preserved Ejection Fraction: Pooled Analysis of 3 Clinical Trials
scientific article published on 06 May 2020
Myocardial infarct: no one size fits all.
artículo científico publicado en 2002
Myocardial metabolic manipulation: a new therapeutic approach in heart failure?
artículo científico publicado en 2005
N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status
artículo científico publicado en 2019
N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).
artículo científico publicado en 2013
N-terminal pro-brain natriuretic peptide (NT-proBNP) predicts the cardio-renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular risk
artículo científico publicado en 2018
NT-proBNP by Itself Predicts Death and Cardiovascular Events in High-Risk Patients With Type 2 Diabetes Mellitus
scientific article published on 23 September 2020
Natriuretic Peptides as Biomarkers of Treatment Response in Clinical Trials of Heart Failure.
artículo científico publicado en 2018
Nature and prognostic importance of abnormal glucose tolerance and diabetes in acute heart failure.
artículo científico publicado en 2007
Neprilysin Inhibition for Heart Failure
artículo científico publicado en 2014
Neprilysin inhibition to treat heart failure: a tale of science, serendipity, and second chances
artículo científico publicado en 2015
Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF).
artículo científico publicado en 2014
Neuroendocrine changes post myocardial infarction: Effects of xamoterol
artículo científico publicado en 1990
Neurohormonal activation in acute heart failure: results from VERITAS.
artículo científico publicado en 2011
Neurohumoral effects of aliskiren in patients with symptomatic heart failure receiving a mineralocorticoid receptor antagonist: the Aliskiren Observation of Heart Failure Treatment study
artículo científico publicado en 2011
Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure
artículo científico publicado en 2007
Neurohumoral pathways in heart failure with preserved systolic function
artículo científico publicado en 2005
New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessment
artículo científico publicado en 2017
New therapeutic options in congestive heart failure: Part I.
artículo científico publicado en 2002
New therapeutic options in congestive heart failure: Part II.
artículo científico publicado en 2002
Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial
artículo científico publicado en 2004
Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis.
artículo científico publicado en 2017
Novel exercise protocol suitable for use on a treadmill or a bicycle ergometer
artículo científico publicado en 1990
Novel extracellular matrix biomarkers as predictors of adverse outcome in chronic heart failure: association between biglycan and response to statin therapy in the CORONA trial
artículo científico publicado en 2014
Novel neuropeptides in the pathophysiology of heart failure: adrenomedullin and endothelin-1
artículo científico publicado en 1999
Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms
scientific article published on 22 April 2020
Omecamtiv Mecarbil in Chronic Heart Failure with Reduced Ejection Fraction, GALACTIC-HF: Baseline Characteristics and Comparison with Contemporary Clinical Trials
artículo científico publicado en 2020
Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction: Rationale and Design of GALACTIC-HF
scientific article published on 06 February 2020
Optimizing heart failure treatment following cardiac resynchronization therapy
scientific article published on 26 September 2019
Organization of heart failure management in European Society of Cardiology member countries: survey of the Heart Failure Association of the European Society of Cardiology in collaboration with the Heart Failure National Societies/Working Groups
artículo científico publicado en 2013
Outcomes and Effect of Treatment According to Etiology in HFrEF: An Analysis of PARADIGM-HF
scientific article published on 08 May 2019
Over 20,000 avoidable coronary deaths in England and Wales in 2000: the failure to give effective treatments to many eligible patients.
artículo científico publicado en 2006
PARADIGM-HF — The Experts' Discussion
article
PIONEER-HF: a new frontier in the role of neprilysin inhibition in the management of heart failure with reduced ejection fraction
scientific article published on 01 November 2019
Palliative care for heart failure
artículo científico publicado en 2002
Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology
scientific article published on May 2009
Palliative care needs in patients hospitalized with heart failure (PCHF) study: rationale and design
artículo científico publicado en 2015
Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both
artículo científico publicado en 2010
Patient perception of the effect of treatment with candesartan in heart failure. Results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme
artículo científico publicado en 2005
Patients strategies for managing medication for chronic heart failure
artículo científico publicado en 2005
Patients with prior coronary artery bypass grafting have a poor outcome after myocardial infarction: an analysis of the VALsartan in acute myocardial iNfarcTion trial (VALIANT)
Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT.
artículo científico publicado en 2012
Personalized medicine and hospitalization for heart failure: if we understand it, we may be successful in treating it
artículo científico publicado en 2019
Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction
artículo científico publicado en 2011
Pharmacologic management of patients with both heart failure and diabetes
artículo científico publicado en 2009
Pharmacological treatment of heart failure with preserved ejection fraction: a glimpse of light at the end of the tunnel?
artículo científico publicado en 2012
Phase III clinical trial end points in acute heart failure syndromes: A virtual roundtable with the acute heart failure syndromes international working group
article
Phosphodiesterase-9 Inhibition in Heart Failure: A Further Opportunity to Augment the Effects of Natriuretic Peptides?
artículo científico publicado en 2019
Physical activity as a determinant of fasting and 2-h post-challenge glucose: a prospective cohort analysis of the NAVIGATOR trial
artículo científico publicado en 2015
Placebo-controlled comparison of candoxatril, an orally active neutral endopeptidase inhibitor, and captopril in patients with chronic heart failure
scientific article published on 01 March 1999
Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study
artículo científico publicado en 2016
Plasma TIMP-4 Predicts Left Ventricular Remodeling After Acute Myocardial Infarction
Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in
artículo científico publicado en 2009
Pneumonia
artículo científico publicado en 1986
Post hoc analyses of SHIFT and PARADIGM-HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: "Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial" by Bocc
article
Potentially detrimental cardiovascular effects of oxygen in patients with chronic left ventricular systolic dysfunction
artículo científico publicado en 2010
Practical approach on frail older patients attended for acute heart failure
artículo científico publicado en 2016
Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practice.
artículo científico publicado en 2001
Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice
artículo científico publicado en 2005
Prediabetes and the risk of diabetes
artículo científico publicado en 2012
Predicting Outcomes Over Time in Patients With Heart Failure, Left Ventricular Systolic Dysfunction, or Both Following Acute Myocardial Infarction
artículo científico publicado en 2016
Predicting heart failure decompensation using cardiac implantable electronic devices: a review of practices and challenges.
artículo científico
Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies
artículo científico publicado en 2012
Predictive value of endostatin in chronic heart failure patients with poor kidney function
artículo científico publicado en 2014
Predictors and Associations With Outcomes of Length of Hospital Stay in Patients With Acute Heart Failure: Results From VERITAS.
artículo científico
Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction
article
Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial
artículo científico publicado en 2012
Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models
artículo científico
Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program
artículo científico publicado en 2009
Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide
artículo científico publicado en 2009
Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)
article
Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance: insight from the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research study
artículo científico publicado en 2013
Predictors of mortality and morbidity in patients with chronic heart failure
artículo científico publicado en 2005
Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT Trial.
artículo científico publicado en 2006
Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial
artículo científico publicado en 2013
Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial
artículo científico publicado en 2009
Predictors of sudden cardiac death in high-risk patients following a myocardial infarction
artículo científico publicado en 2020
Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study
artículo científico publicado en 2008
Predominance of heart failure in the Heart of Soweto Study cohort: emerging challenges for urban African communities
artículo científico publicado en 2008
Prevalence and profile of "seasonal frequent flyers" with chronic heart disease: Analysis of 1598 patients and 4588 patient-years follow-up
scientific article published on 02 January 2019
Prevalence and prognostic impact of bundle branch block in patients with heart failure: evidence from the CHARM programme
artículo científico publicado en 2007
Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortality
artículo científico publicado en 2017
Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes
artículo científico publicado en 2017
Prevalence, incidence, primary care burden and medical treatment of angina in Scotland: age, sex and socioeconomic disparities: a population-based study
artículo científico publicado en 2006
Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program
artículo científico publicado en 2006
Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial
artículo científico publicado en 2008
Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction
artículo científico publicado en 2006
Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland
artículo científico publicado en 2009
Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared With Valsartan in HFpEF
scientific article published on 11 November 2019
Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction
scientific article published on 10 April 2019
Pro-gastrin-releasing peptide and outcome in patients with heart failure and anaemia: results from the RED-HF study
scientific article published on 25 August 2018
Profile of microvolt T-wave alternans testing in 1003 patients hospitalized with heart failure
article
Prognostic Implications of Changes in Amino-Terminal Pro-B-Type Natriuretic Peptide in Acute Decompensated Heart Failure: Insights From ASCEND-HF
scientific article published on 4 April 2019
Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure
artículo científico publicado en 2016
Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HF
artículo científico publicado en 2019
Prognostic Modeling in Heart Failure: Time for a Reboot
artículo científico publicado en 2018
Prognostic Models Derived in PARADIGM-HF and Validated in ATMOSPHERE and the Swedish Heart Failure Registry to Predict Mortality and Morbidity in Chronic Heart Failure
scientific article published on 29 January 2020
Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure
artículo científico publicado en 2015
Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction
artículo científico publicado en 2016
Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation
artículo científico publicado en 2017
Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial
artículo científico publicado en 2013
Prognostic impact of pulmonary arterial hypertension: A population-based analysis
article
Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study
artículo científico publicado en 2008
Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study.
artículo científico publicado en 2017
Prognostic importance of temporal changes in resting heart rate in heart failure patients: an analysis of the CHARM program
artículo científico publicado en 2014
Prognostic value of CXCL16 in patients with left ventricular systolic dysfunction and heart failure
artículo científico publicado en 2013
Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial
artículo científico
Prospective relationships between body weight and physical activity: an observational analysis from the NAVIGATOR study
artículo científico publicado en 2015
Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia
artículo científico publicado en 2014
Public awareness of heart failure in Europe: first results from SHAPE
article
Pulse pressure is not an independent predictor of outcome in type 2 diabetes patients with chronic kidney disease and anemia—the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT)
scientific article published on 26 March 2015
QRS duration alone to select patients for cardiac resynchronization therapy: flying in the face of the evidence?
article
Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus.
artículo científico publicado en 2015
Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or both
artículo científico publicado en 2008
Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial
artículo científico publicado en 2010
Randomized Trial Comparing Proactive, High-Dose versus Reactive, Low-Dose Intravenous Iron Supplementation in Hemodialysis (PIVOTAL): Study Design and Baseline Data
artículo científico publicado en 2018
Randomized Trials Versus Common Sense and Clinical Observation: JACC Review Topic of the Week
artículo científico publicado en 2020
Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT).
artículo científico publicado en 2016
Rationale and design for the development of a novel nitroxyl donor in patients with acute heart failure
artículo científico publicado en 2019
Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).
artículo científico publicado en 2008
Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF).
artículo científico publicado en 2010
Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome.
artículo científico publicado en 2009
Rationale and design of the phase 2b clinical trials to study the effects of the partial adenosine A1-receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced (PANTHEON) and preserved (PANACHE) ejection fraction
artículo científico publicado en 2018
Rationale and trial design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON).
artículo científico publicado en 2013
Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial.
artículo científico publicado en 2014
Rationale for and design of the TRUE-AHF trial: the effects of ularitide on the short-term clinical course and long-term mortality of patients with acute heart failure
artículo científico publicado en 2016
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo
artículo científico publicado en 2015
Rationale—Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease
article
Re-Examination of the BEST Trial Using Composite Outcomes, Including Emergency Department Visits
article by Li Shen et al published August 2017 in JACC: Heart Failure
Readmission and death in patients admitted with new-onset versus worsening of chronic heart failure: insights from a nationwide cohort
scientific article published on 30 March 2020
Recommendations on pre-hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Em
artículo científico
Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank
artículo científico publicado en 2007
Red cell distribution width has incremental prognostic value to B-type natriuretic peptide in acute heart failure.
artículo científico publicado en 2009
Redefining heart failure phenotypes based on ejection fraction
artículo científico publicado en 2018
Reduced Risk of Hyperkalemia During Treatment of Heart Failure With Mineralocorticoid Receptor Antagonists by Use of Sacubitril/Valsartan Compared With Enalapril: A Secondary Analysis of the PARADIGM-HF Trial
artículo científico publicado en 2016
Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial
scientific article published on 11 February 2019
Referral for Specialist Follow-up and Its Association With Post-discharge Mortality Among Patients With Systolic Heart Failure (from the National Heart Failure Audit for England and Wales).
artículo científico publicado en 2016
Regional cardiac dysfunction and outcome in patients with left ventricular dysfunction, heart failure, or both after myocardial infarction.
artículo científico publicado en 2015
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction
artículo científico publicado en 2004
Relation of High Serum Bilirubin to Short-Term Mortality Following a Myocardial Infarction Complicated by Left Ventricular Systolic Dysfunction (from the High-Risk Myocardial Infarction Database Initiative).
artículo científico publicado en 2018
Relation of Volume Overload to Clinical Outcomes in Acute Heart Failure (From ASCEND-HF)
scientific article published on 03 August 2018
Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy
artículo científico
Relationship between angina pectoris and outcomes in patients with heart failure and reduced ejection fraction: an analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
artículo científico publicado en 2014
Relationship between baseline physical activity assessed by pedometer count and new-onset diabetes in the NAVIGATOR trial.
artículo científico publicado en 2018
Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve).
artículo científico
Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction
artículo científico publicado en 2019
Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)–Added trial
article by John McMurray et al published May 2006 in American Heart Journal
Relative Importance of History of Heart Failure Hospitalization and N-Terminal Pro-B-Type Natriuretic Peptide Level as Predictors of Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.
artículo científico publicado en 2015
Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure.
artículo científico publicado en 2018
Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction.
artículo científico publicado en 2015
Renal function as a predictor of outcome in a broad spectrum of patients with heart failure
artículo científico publicado en 2006
Renal function estimation and Cockroft-Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart 'OMics' in AGEing (HOMAGE) and the high-risk myoc
artículo científico publicado en 2016
Renal function stratified dose comparisons of eplerenone versus placebo in the EMPHASIS-HF trial
scientific article published on 15 February 2019
Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trial.
artículo científico publicado en 2016
Renin angiotensin blockade in heart failure with preserved ejection fraction: the signal gets stronger
scientific article published on 08 September 2006
Renin-Angiotensin System Inhibition, Worsening Renal Function, and Outcome in Heart Failure Patients With Reduced and Preserved Ejection Fraction: A Meta-Analysis of Published Study Data
artículo científico publicado en 2017
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
artículo científico publicado en 2020
Reply
Reply
Reply
Reply
Reply to the letter by Dr Erqou regarding “Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients”
Reply: An Opportunity to Definitively Evaluate the Theoretical Risks of Neprilysin Inhibition
scientific article published on 01 November 2017
Reply: Different Phenotype Characterization in PARAGON-HF: An Unresolved Puzzle in Patients With HFpEF
artículo científico publicado en 2020
Reply: Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction
artículo científico publicado en 2020
Reply: Mineralocorticoid Receptor Antagonists, Blood Pressure, and Drug Discontinuation
artículo científico publicado en 2020
Reply: NT-proBNP in Heart Failure With Preserved Ejection Fraction: Quest for a Marker Reflecting the Truth
artículo científico publicado en 2020
Reply: The PARAGON-HF Trial: Toward Extension to Patients With HF Middle Range Ejection Fraction
artículo científico publicado en 2020
Reply: Time for an "Atrial-Watchful" Approach for Heart Failure Patients With a Cardiac Implantable Electronic Device
scientific article published on 01 March 2018
Reply: To PMID 23141494.
artículo científico publicado en 2013
Reply: does speckle tracking really improve diagnosis and risk stratification in patients with HF with normal EF?
artículo científico publicado en 2014
Reporting of Lost to Follow-Up and Treatment Discontinuation in Pharmacotherapy and Device Trials in Chronic Heart Failure: A Systematic Review.
artículo científico publicado en 2016
Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT).
artículo científico publicado en 2005
Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme
artículo científico publicado en 2006
Response by Claggett et al to Letter Regarding Article, "Comparison of Time-to-First Event and Recurrent-Event Methods in Randomized Clinical Trials"
artículo científico publicado en 2019
Response by Jackson et al to Letter Regarding Article, "Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF"
artículo científico publicado en 2020
Response to Letter Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della So
artículo científico publicado en 2015
Response to Letter Regarding Article, “Effect of Celecoxib on Cardiovascular Events and Blood Pressure in Two Trials for the Prevention of Colorectal Adenomas”
Response to Letter Regarding Article, “Galectin-3 and Cardiac Function in Survivors of Acute Myocardial Infarction”.
artículo científico publicado en 2013
Response to Letter Regarding Article, “Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure”
Response to Letter Regarding Article, “Pathogenesis of Sudden Unexpected Death in a Clinical Trial of Patients With Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both”
Response to The J-Point Revisited
Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation".
artículo científico publicado en 2014
Results of a reevaluation of cardiovascular outcomes in the RECORD trial
artículo científico publicado en 2013
Retinopathy and clinical outcomes in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia.
artículo científico publicado en 2014
Retinopathy, Neuropathy, and Subsequent Cardiovascular Events in Patients with Type 2 Diabetes and Acute Coronary Syndrome in the ELIXA: The Importance of Disease Duration
artículo científico publicado en 2018
Return to the Workforce After First Hospitalization for Heart Failure: A Danish Nationwide Cohort Study
artículo científico publicado en 2016
Reversible renal failure after combined treatment with enalapril and frusemide in a patient with congestive heart failure
Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial
artículo científico publicado en 2016
Risk factors for heart failure in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl
artículo científico publicado en 2014
Risk of Incident Heart Failure in Patients With Diabetes and Asymptomatic Left Ventricular Systolic Dysfunction
scientific article published on 06 April 2018
Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca
artículo científico publicado en 2015
Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials
artículo científico publicado en 2017
Risk prediction in patients with heart failure: a systematic review and analysis
artículo científico
Risk stratification according to insulin type: reply.
artículo científico publicado en 2018
Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus
artículo científico
Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study
artículo científico publicado en 2013
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
artículo científico publicado en 2009
Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis
artículo científico publicado en 2007
Rosuvastatin in older patients with systolic heart failure
artículo científico publicado en 2007
SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
artículo científico publicado en 2016
SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review
artículo científico publicado en 2018
Sacubitril/Valsartan (LCZ696) in Heart Failure
artículo científico publicado en 2017
Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure
artículo científico publicado en 2019
Sacubitril/Valsartan and Sudden Cardiac Death According to Implantable Cardioverter-Defibrillator Use and Heart Failure Cause: A PARADIGM-HF Analysis
scientific article published on 04 September 2020
Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced Ejection Fraction.
artículo científico publicado en 2019
Sacubitril/Valsartan: Neprilysin Inhibition 5 Years After PARADIGM-HF
scientific article published on 01 October 2020
Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in PARADIGM-HF.
artículo científico publicado en 2017
Safety and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or Worsening Renal Function
article
Screening for left ventricular dysfunction in the community: role of hand held echocardiography and brain natriuretic peptides
⬇️
artículo científico publicado el 1 de noviembre de 2003
Seasonal variation in morbidity and mortality related to atrial fibrillation.
artículo científico publicado en 2004
Seasonal variations in cardiovascular disease
artículo científico publicado en 2017
Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
artículo científico publicado en 2015
Selecting patients for cardiac resynchronization therapy: electrical or mechanical dyssynchrony?
artículo científico publicado en 2006
Selecting patients for cardiac resynchronization therapy: the fallacy of echocardiographic dyssynchrony.
artículo científico publicado en 2009
Self-care management of heart failure: practical recommendations from the Patient Care Committee of the Heart Failure Association of the European Society of Cardiology
artículo científico publicado en 2010
Serum Chloride and Sodium Interplay in Patients With Acute Myocardial Infarction and Heart Failure With Reduced Ejection Fraction: An Analysis From the High-Risk Myocardial Infarction Database Initiative
artículo científico publicado en 2017
Serum Uric Acid, Influence of Sacubitril/Valsartan, and Cardiovascular Outcomes in Heart Failure with Preserved Ejection Fraction: PARAGON-HF
artículo científico publicado en 2020
Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction
artículo científico publicado en 2010
Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment
artículo científico publicado en 2016
Sex Differences in Clinical Characteristics and Prognosis in a Broad Spectrum of Patients With Heart Failure
article
Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial
artículo científico publicado en 2012
Sex differences in incidence, mortality, and survival in individuals with stroke in Scotland, 1986 to 2005.
artículo científico publicado en 2009
Sex differences in mineralocorticoid receptor antagonist trials: a pooled analysis of three large clinical trials
artículo científico publicado en 2020
Sex-Related Differences in Heart Failure With Preserved Ejection Fraction
artículo científico publicado en 2019
Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: the study of patients intolerant of converting enzyme inhibitors registry
article
Sex-specific cardiovascular structure and function in heart failure with preserved ejection fraction
artículo científico publicado en 2014
Short-term and long-term outcomes in 133,429 emergency patients admitted with angina or myocardial infarction in Scotland, 1990-2000: population-based cohort study.
artículo científico publicado en 2006
Should we SHIFT our thinking about digoxin? Observations on ivabradine and heart rate reduction in heart failure
artículo científico publicado en 2012
Site Selection and Performance in Clinical Trials
Site selection for heart failure clinical trials in the USA.
artículo científico publicado en 2015
Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology
artículo científico publicado en 2012
Soluble glycoprotein 130 predicts fatal outcomes in chronic heart failure: analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
artículo científico
Spectral microvolt T-wave alternans testing has no prognostic value in patients recently hospitalized with decompensated heart failure
article
Statins and chronic heart failure: do we need a large-scale outcome trial?
artículo científico publicado en 2002
Statins in the Prevention and Treatment of Heart Failure: a Review of the Evidence
artículo científico publicado en 2019
Statistical Controversies in Reporting of Clinical Trials: Part 2 of a 4-Part Series on Statistics for Clinical Trials.
artículo científico
Stroke Risk in Patients With Reduced Ejection Fraction After Myocardial Infarction Without Atrial Fibrillation
artículo científico publicado en 2018
Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience.
artículo científico publicado en 2011
Study design of Dal-GenE, a pharmacogenetic trial targeting reduction of cardiovascular events with dalcetrapib
artículo científico publicado en 2020
Substantial between-hospital variation in outcome following first emergency admission for heart failure.
artículo científico publicado en 2002
Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both
article
Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population
⬇️
artículo científico publicado el 20 de septiembre de 1997
Synergism of histidyl dipeptides as antioxidants
article
Systolic Blood Pressure in Heart Failure With Preserved Ejection Fraction Treated With Sacubitril/Valsartan
artículo científico publicado en 2020
Systolic blood pressure reduction during the first 24 h in acute heart failure admission: friend or foe?
artículo científico publicado en 2017
Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF.
artículo científico publicado en 2017
Talking to patients with heart failure about end of life
artículo científico publicado en 2018
Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).
artículo científico publicado en 2004
Telomere length and outcomes in ischaemic heart failure: data from the COntrolled ROsuvastatin multiNAtional Trial in Heart Failure (CORONA).
artículo científico publicado en 2015
Temporal Trends and Patterns in Mortality After Incident Heart Failure: A Longitudinal Analysis of 86 000 Individuals
scientific article published on 03 September 2019
Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals
artículo científico publicado en 2017
Temporal trends and risk factors for readmission for infections, gastrointestinal and immobility complications after an incident hospitalisation for stroke in Scotland between 1997 and 2005.
artículo científico publicado en 2015
Temporal trends in hospitalisation for stroke recurrence following incident hospitalisation for stroke in Scotland
artículo científico publicado en 2010
Terminology and definition of changes renal function in heart failure.
artículo científico publicado en 2014
Tezosentan in patients with acute heart failure: design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS).
artículo científico publicado en 2005
The Aliskiren Trial to Minimize OutcomeS in Patients with HEart failure trial (ATMOSPHERE): revised statistical analysis plan and baseline characteristics.
artículo científico publicado en 2015
The Dapagliflozin And Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context
scientific article published on 03 January 2020
The Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure (DAPA-HF) trial: baseline characteristics
artículo científico publicado en 2019
The Emerging Potential of the Apelin-APJ System in Heart Failure.
artículo científico
The Heart failure and Optimal Outcomes from Pharmacy Study (HOOPS): rationale, design, and baseline characteristics
artículo científico publicado en 2011
The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
artículo científico publicado en 2015
The ICD in Heart Failure - Time for a Rethink?
artículo científico publicado en 2016
The J-curve hypothesis
artículo científico publicado en 1992
The Metabolodiuretic Promise of Sodium-Dependent Glucose Cotransporter 2 Inhibition: The Search for the Sweet Spot in Heart Failure
artículo científico publicado en 2017
The Serendipitous Story of SGLT2 Inhibitors in Heart Failure
scientific article published on 18 March 2019
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
artículo científico publicado en 2012
The assessment of the HO· scavenging action of therapeutic agents
artículo científico publicado en 1994
The association between meteorological events and acute heart failure: new insights from ASCEND-HF.
artículo científico publicado en 2014
The clinical course of health status and association with outcomes in patients hospitalized for heart failure: insights from ASCEND-HF
artículo científico publicado en 2015
The clinical relevance of adrenomedullin: a promising profile?
artículo científico publicado en 2004
The complex nature of informal care in home-based heart failure management
artículo científico publicado en 2008
The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry.
artículo científico publicado en 2006
The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting
artículo científico publicado en 2015
The dual endothelin converting enzyme/neutral endopeptidase inhibitor SLV-306 (daglutril), inhibits systemic conversion of big endothelin-1 in humans
artículo científico publicado en 2012
The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials
artículo científico publicado en 2015
The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
artículo científico publicado en 2006
The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HF.
artículo científico publicado en 2017
The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial.
artículo científico publicado en 2011
The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality
artículo científico publicado en 2008
The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trial
artículo científico publicado en 2013
The impact of kidney function on outcomes following high risk myocardial infarction: findings from 27 610 patients
artículo científico publicado en 2013
The incremental prognostic and clinical value of multiple novel biomarkers in heart failure
artículo científico publicado en 2016
The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarction
artículo científico publicado en 2010
The irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial: rationale and design
artículo científico publicado en 2005
The large-scale placebo-controlled beta-blocker studies in systolic heart failure revisited: results from CIBIS-II, COPERNICUS and SENIORS-SHF compared with stratified subsets from MERIT-HF.
artículo científico publicado en 2013
The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan
artículo científico publicado en 2016
The novel urinary proteomic classifier HF1 has similar diagnostic and prognostic utility to BNP in heart failure
artículo científico publicado en 2020
The past, present and future of renin-angiotensin aldosterone system inhibition
artículo científico publicado en 2012
The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
artículo científico publicado en 2012
The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE
scientific article published on 30 April 2020
The prevalence, nature, and importance of hematologic abnormalities in heart failure
artículo científico publicado en 2006
The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis
scientific article published on 4 August 2009
The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes
artículo científico publicado en 2018
The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction: the VALIANT Echo Study.
artículo científico publicado en 2007
The reproducibility of symptoms during a submaximal exercise test in chronic heart failure.
artículo científico publicado en 1998
The rise and fall of myotrophin in heart failure**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology
artículo científico publicado en 2003
The role of angiotensin II receptor blockers in the management of heart failure
The statin wars
artículo científico publicado en 2003
The treatment of heart failure with preserved ejection fraction ("diastolic heart failure").
artículo científico publicado en 2006
The year in cardiology: heart failure
artículo científico publicado en 2020
The year in heart failure
artículo científico publicado en 2004
Thirty Years of Evidence on the Efficacy of Drug Treatments for Chronic Heart Failure With Reduced Ejection Fraction: A Network Meta-Analysis
artículo científico publicado en 2017
Three-question set from Michigan Neuropathy Screening Instrument adds independent prognostic information on cardiovascular outcomes: analysis of ALTITUDE trial.
artículo científico publicado en 2017
Thyroid-stimulating hormone and clinical outcomes: the CORONA trial (controlled rosuvastatin multinational study in heart failure).
artículo científico publicado en 2014
Time to rename the middle child of heart failure: heart failure with mildly reduced ejection fraction
artículo científico publicado en 2020
Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency
artículo científico publicado en 2016
Transthoracic echocardiography: a survey of current practice in the UK
artículo científico publicado en 2008
Treatment With Dalcetrapib Modifies the Relationship Between High-Density Lipoprotein Cholesterol and C-Reactive Protein.
artículo científico publicado en 2016
Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
scientific article published on 19 December 2018
Treatment of anemia with darbepoetin alfa in systolic heart failure
artículo científico publicado en 2013
Treatment of chronic heart failure: a comparison between the major guidelines
artículo científico publicado en 2006
Treatment of heart failure with spironolactone--trial and tribulations
artículo científico publicado en 2004
Treatment of severe hypertriglyceridaemia
artículo científico publicado en 2014
Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research Database
⬇️
artículo científico publicado en 2010
Trends in case-fatality in 22968 patients admitted for the first time with atrial fibrillation in Scotland, 1986-1995.
artículo científico
Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986–1996
article
Trends in hospitalization for heart failure in Scotland, 1990–1996. An epidemic that has reached its peak?
article
Trends in incidence and in short term survival following a subarachnoid haemorrhage in Scotland, 1986-2005: a retrospective cohort study
artículo científico publicado en 2011
Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study
artículo científico publicado en 2012
Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology.
artículo científico publicado en 2018
Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction
artículo científico publicado en 2017
Uncertainty in the treatment of anemia in chronic kidney disease.
artículo científico publicado en 2005
Updated risk factors should be used to predict development of diabetes.
artículo científico publicado en 2017
Use of the Win Ratio in Cardiovascular Trials
artículo científico publicado en 2020
Usefulness of Right Ventricular Fractional Area Change to Predict Death, Heart Failure, and Stroke Following Myocardial Infarction (from the VALIANT ECHO Study)
article
Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
artículo científico publicado en 2009
Using measures of disease progression to determine therapeutic effect: a sirens' song
artículo científico publicado en 2006
VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context
artículo científico publicado en 2003
VICTORIA in context
artículo científico publicado en 2020
Val-HeFT: do angiotensin-receptor blockers benefit heart failure patients already receiving ACE inhibitor therapy?
artículo científico publicado en 2005
Valsartan in acute myocardial infarction trial (VALIANT): rationale and design.
artículo científico publicado en 2000
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
artículo científico publicado en 2003
Variation in hospital performance for heart failure management in the National Heart Failure Audit for England and Wales.
artículo científico publicado en 2016
Venous thromboembolism and cardiovascular risk: results from the NAVIGATOR trial
artículo científico publicado en 2014
Visit-to-visit blood pressure variation and outcomes in heart failure with reduced ejection fraction: findings from the Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms trial
artículo científico publicado en 2020
Visit-to-visit blood pressure variation is associated with outcomes in a U-shaped fashion in patients with myocardial infarction complicated with systolic dysfunction and/or heart failure: findings from the EPHESUS and OPTIMAAL trials
artículo científico publicado en 2018
Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme
artículo científico publicado en 2008
What are the clinical consequences of anemia in patients with chronic heart failure?
artículo científico publicado en 2004
What can we learn from RELAX-AHF compared to previous AHF trials and what does the future hold?
artículo científico publicado en 2015
What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE?
artículo científico publicado en 2012
What works in chronic care management: the case of heart failure.
artículo científico publicado en 2009
When to stop a clinical trial early for benefit: lessons learned and future approaches
artículo científico
Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
artículo científico publicado en 2004
Which patients with heart failure should receive specialist palliative care?
artículo científico publicado en 2018
Who Benefits From a Defibrillator-Balancing the Risk of Sudden Versus Non-sudden Death
Why and when should we worry about worsening renal function?
artículo científico publicado en 2013
Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis
artículo científico publicado en 2017
World Heart Federation Roadmap for Heart Failure
scientific article published on 01 September 2019
Worsening heart failure, a critical event during hospital admission for acute heart failure: results from the VERITAS study
article
Worsening renal function and outcome in heart failure patients with preserved ejection fraction and the impact of angiotensin receptor blocker treatment.
artículo científico publicado en 2014
Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme
artículo científico publicado en 2016
Ximelagatran compared with warfarin for the prevention of systemic embolism and stroke. An imputed placebo analysis.
artículo científico publicado en 2005
[Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease]
artículo científico publicado en 2004
β blockers, atrial fibrillation, and heart failure
artículo científico publicado en 2014
β1-Adrenoreceptor Autoantibodies in Heart Failure: Physiology and Therapeutic Implications
artículo científico publicado en 2020